CardieX Crecimiento futuro

Future controles de criterios 5/6

Se prevé un crecimiento anual de los beneficios y los ingresos de CardieX de 90.7% y 54.8% por año respectivamente. Se prevé que el BPA crezca en un 120.1% al año. Se espera que la rentabilidad financiera sea de 1% en 3 años.

Información clave

90.7%

Tasa de crecimiento de los beneficios

120.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.2%
Tasa de crecimiento de los ingresos	54.8%
Rentabilidad financiera futura	1.0%
Cobertura de analistas	Low
Última actualización	06 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Previsiones de crecimiento de beneficios e ingresos

ASX:CDX - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2027	70	40	40	40	1
6/30/2026	51	24	24	24	1
6/30/2025	17	-3	-4	-4	1
6/30/2024	13	-7	-8	-8	N/A
3/31/2024	13	-8	-7	-7	N/A
12/31/2023	14	-9	-5	-5	N/A
9/30/2023	10	-14	-9	-9	N/A
6/30/2023	6	-19	-12	-12	N/A
3/31/2023	5	-16	-11	-11	N/A
12/31/2022	4	-14	-10	-10	N/A
9/30/2022	4	-13	-10	-9	N/A
6/30/2022	5	-12	-10	-9	N/A
3/31/2022	5	-11	-9	-8	N/A
12/31/2021	5	-10	-8	-8	N/A
9/30/2021	5	-7	-6	-6	N/A
6/30/2021	6	-5	-4	-4	N/A
3/31/2021	5	-4	-3	-3	N/A
12/31/2020	5	-3	-2	-2	N/A
9/30/2020	5	-3	-2	-2	N/A
6/30/2020	5	-3	-2	-2	N/A
3/31/2020	5	-3	-2	-2	N/A
12/31/2019	5	-4	-2	-2	N/A
9/30/2019	5	-3	-2	-2	N/A
6/30/2019	5	-3	-3	-2	N/A
3/31/2019	5	-3	-3	-3	N/A
12/31/2018	4	-3	-3	-3	N/A
9/30/2018	4	-3	-2	-2	N/A
6/30/2018	4	-3	-2	-2	N/A
3/31/2018	5	-3	N/A	-2	N/A
12/31/2017	5	-4	N/A	-2	N/A
9/30/2017	5	-4	N/A	-3	N/A
6/30/2017	5	-4	N/A	-3	N/A
3/31/2017	5	-4	N/A	-4	N/A
12/31/2016	5	-4	N/A	-4	N/A
9/30/2016	5	-5	N/A	-5	N/A
6/30/2016	5	-5	N/A	-5	N/A
3/31/2016	5	-4	N/A	-4	N/A
12/31/2015	4	-4	N/A	-4	N/A
9/30/2015	5	-3	N/A	-3	N/A
6/30/2015	5	-1	N/A	-2	N/A
3/31/2015	5	-2	N/A	-2	N/A
12/31/2014	5	-2	N/A	-3	N/A
9/30/2014	5	-2	N/A	-2	N/A
6/30/2014	5	-3	N/A	-1	N/A
3/31/2014	6	-2	N/A	0	N/A
12/31/2013	6	0	N/A	1	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que CDX sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Se prevé que CDX sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que CDX sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (54.8% al año) de CDX crezcan más rápidamente que los del mercado Australian (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (54.8% al año) de CDX crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de CDX sea baja dentro de 3 años (1%).

CardieX Crecimiento futuro

Future controles de criterios 5/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

New minor risk - Share price stability

CardieX Limited, Annual General Meeting, Nov 29, 2024

Full year 2024 earnings released: AU$0.034 loss per share (vs AU$0.14 loss in FY 2023)

CardieX (ASX:CDX) Is Carrying A Fair Bit Of Debt

Full year 2024 earnings released: AU$0.038 loss per share (vs AU$0.14 loss in FY 2023)

New major risk - Market cap size

Less than half of directors are independent

CardieX Limited Appoints Charlie Taylor as an Independent Non-Executive Director, Effective 1 March 2024

CardieX Limited has completed a Follow-on Equity Offering in the amount of AUD 4 million.

CardieX Limited has filed a Follow-on Equity Offering in the amount of AUD 7.62 million.

CardieX Limited, Annual General Meeting, Nov 30, 2023

CardieX Limited Announces Resignation of Lesa Musatto as Independent Non-Executive Director

Full year 2023 earnings released: AU$0.15 loss per share (vs AU$0.12 loss in FY 2022)

New minor risk - Financial data availability

CardieX Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

CardieX Limited announced that it expects to receive AUD 2.3 million in funding

First half 2023 earnings released: AU$0.072 loss per share (vs AU$0.053 loss in 1H 2022)

CardieX Limited has completed a Follow-on Equity Offering in the amount of AUD 4.044413 million.

CardieX Limited Appoints Reid Yeoman as the Group's New Us Based Chief Financial Officer

CardieX Limited (ASX:CDX) acquired All the Assets of Blumio, Inc.

Less than half of directors are independent

CardieX Limited, Annual General Meeting, Nov 30, 2022

CardieX Limited Auditor Raises 'Going Concern' Doubt

Full year 2022 earnings released: AU$0.12 loss per share (vs AU$0.059 loss in FY 2021)

CardieX Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million.

Full year 2022 earnings released: AU$0.11 loss per share (vs AU$0.064 loss in FY 2021)

CardieX Limited has completed a Follow-on Equity Offering in the amount of AUD 4.330001 million.

CardieX Limited Announces FDA 510(K) Submission for Conneqt Pulse Dual Blood Pressure and Arterial Health Monitor

FDA Update for CONNEQT Companion App of Cardiex Limited

CardieX Limited Announces Appointment of Lesa Musatto as an Independent, Non-Executive Director

Less than half of directors are independent

CardieX Submits FDA Application for its CONNEQT App

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Global Health Technology Company CardieX and Mobvoi Launch a Revolutionary Heart Health Monitoring Smartwatch for Consumers

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2020)

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2020)

CardieX Launches CONNEQT™

What Can We Learn About CardieX's (ASX:CDX) CEO Compensation?

Shareholders Are Thrilled That The CardieX (ASX:CDX) Share Price Increased 169%

CardieX Limited Announces New Devices on Track for Launch in 2021

CardieX Limited Announces Executive Appointments

Have Insiders Been Buying CardieX Limited (ASX:CDX) Shares?

CardieX Limited, Annual General Meeting, Dec 11, 2020

CardieX Limited Limited Announces Commercial Partnership Agreement with Mobvoi for New Health Smartwatch

Full year earnings released - AU$0.0046 loss per share

Full year earnings released - AU$0.0046 loss per share

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento